Title: A phase I study to characterize the multiple-dose pharmacokinetics, pharmacodynamics and safety of new enteric-coated triflusal formulations in healthy male volunteers.
Journal: Expert opinion on drug metabolism & toxicology 20111201
Title: Comparative effects of triflusal, S-adenosylmethionine, and dextromethorphan over intestinal ischemia/reperfusion injury.
Journal: TheScientificWorldJournal 20110101
Title: Electrochemical behavior of triflusal, aspirin and their metabolites at glassy carbon and boron doped diamond electrodes.
Journal: Combinatorial chemistry & high throughput screening 20100801
Title: Eicosanoids in the innate immune response: TLR and non-TLR routes.
Journal: Mediators of inflammation 20100101
Title: Photonucleophilic addition of the epsilon-amino group of lysine to a triflusal metabolite as a mechanistic key to photoallergy mediated by the parent drug.
Journal: ChemMedChem 20090701
Title: Protective effects of triflusal on secondary thrombus growth and vascular cyclooxygenase-2.
Journal: Journal of thrombosis and haemostasis : JTH 20080801
Title: Salicylates increase insulin secretion in healthy obese subjects.
Journal: The Journal of clinical endocrinology and metabolism 20080701
Title: Spectroscopic and chromatographic characterization of triflusal delivery systems prepared by using supercritical impregnation technologies.
Journal: Journal of pharmaceutical and biomedical analysis 20080213
Title: A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study.
Journal: Alzheimer disease and associated disorders 20080101
Title: The study of the influence of surfactant charge on alkaline hydrolysis reactions of acetylsalicylic acid (ASA) and triflusal (TFL) using spectrophotometric methods.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20070701
Title: Inhibition of cardiac hypertrophy by triflusal (4-trifluoromethyl derivative of salicylate) and its active metabolite.
Journal: Molecular pharmacology 20060401
Title: Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers.
Journal: European journal of clinical pharmacology 20050401
Title: Protective effect of triflusal and its main metabolite HTB in an in vitro model of anoxia-reoxygenation in rat brain slices: comparison with acetylsalicylic and salicylic acids.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 20050101
Title: Simultaneous determination of triflusal and its major active metabolite, 2-hydroxy-4-trifluoromethyl benzoic acid, in rat and human plasma by high-performance liquid chromatography.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225
Title: Activation of monocytic cells through Fc gamma receptors induces the expression of macrophage-inflammatory protein (MIP)-1 alpha, MIP-1 beta, and RANTES.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20020915
Title: Effects of the nuclear factor-kappaB inhibitors 2-hydroxy-4-trifluoromethylbenzoic acid and aspirin on micturition in rats with normal and inflamed bladder.
Journal: The Journal of urology 20011101
Title: Photochemistry of 2-hydroxy-4-trifluoromethylbenzoic acid, major metabolite of the photosensitizing platelet antiaggregant drug triflusal.
Journal: Photochemistry and photobiology 20010501
Title: Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
Journal: Molecular pharmacology 19990401
